Korea is considered as an exemplary model in the fight against the disease. It means that the country
19”(CNN) and “Special Report: How Korea trounced U.S. in race to test people for coronavirus” (Reuter).
the disease and engaging in economic activities at the same time. Specifically, the fact that the
country successfully respond to COVID-19 with the aggressive testing, isolation of people confirmed with
the disease, and social distancing only without closing national or local borders was highly recognized by
the world as evidenced by reports from “What we can learn from South Korea about containing COVID-
19”(CNN) and “Special Report: How Korea trounced U.S. in race to test people for coronavirus” (Reuter). 

COVID-19 is an infectious disease that has impacted on the life of humanity most significantly since
short term, but also we should prepare measures from the mid/long-term perspectives.
the 4th industrial revolution. The discussions on a new normal after COVID-19 are already made. As
noted by Thomas Freidman, an American opinion columnist and author of ‘The World is Flat: A Brief
History of the 21st Century’, the world is now divided into the world B.C. -Before Corona- and the world
A.C. -After Corona. It implies that we should not only respond to the global COVID-19 pandemic in the
short term, but also we should prepare measures from the mid/long-term perspectives. 

With regard to this, this article first provides a review on discussions on the essence of socio-economic impact of COVID-19 and the roles of innovation system to move forward in the future as well as strategies to achieve the goals. innovation system to move forward in the future as well as strategies to achieve the goals.

This article is a revised version of the executive summary of a STPI’s 2019 report named Analysis of Energy Research Fronts, written in Chinese. The report offers a broad perspective widely recognized as valuable information about the development of scientific research. This efficiency of government resources. Research fronts in the Clarivate Analytics database are widely recognized as valuable information about the development of scientific research. 

This study was conducted to identify the Top 30 (most frequently cited) energy research fronts (ERFs) extracted from 8,814 research fronts across all disciplines published by Clarivate Analytics in March 2019. The 676 core papers related to the Top 30 ERFs were elaborately discussed with analyzing their global distribution, trends in the citation, publishing institutes, and funding agencies. 

Furthermore, the prominent works associated with the Top 30 ERFs were clearly delineated. The statistical results indicated that the 42.5% and 39.8% of the 676 core papers were respectively published by the USA and China research groups. However, there were only 14 core papers published by research groups of Taiwan, 5 of them accomplished by international collaborations. Finally, the Top 30 ERFs were grouped into 16 subjects for further analysis. 

More enterprises are now integrating mobile cloud computing into their operations. This study combines
The behavioral intention then affects their use behavior and performance impact (user satisfaction).
form a new model. A questionnaire was administered to the employees of a company that has applied mobile cloud computing. The purpose is to investigate what happens when this new technology is introduced in the workplace and what the influencing factors may be. 

After confirming the validity and reliability of the instrument through a pilot, 239 formal responses were collected and analyzed using descriptive statistics, one-way ANOVA, and structural equation modeling. It was found that employees’ perception of how well the technology fits the nature of their work positively affects their effort expectancy of the technology and their view of the task-technology fit, which in turn affects their performance impact (user satisfaction) and actual technology use. Also, employees’ behavioral intention to use this new information technology is affected by their perceived effort expectancy, performance expectancy, and facilitating conditions. The behavioral intention then affects their use behavior and performance impact (user satisfaction).

As we move forward in the midst of such rapid and uncertain changes in our landscape, it is important to develop countermeasures based on predictions of the future. The digitalization and other scientific and technological advances are important identified through this research to develop their investment strategies in the post COVID-19 era.

Technologies that will soon to be considered as important in our society and come up with measures responding them in advance. In the meantime, it is expected that the government, research institutes, and companies can apply the emerging technologies identified through this research to develop their investment strategies in the post COVID-19 era.

The COVID-19 has exposed the fragile limits of healthcare facilities and infrastructures around the world. Even in the countries with best healthcare system, their overall preparedness seems to be weak in handling this situation. However, situation is even have responded during the outbreak of this this pandemic. Almost all ECO Countries are under the state of emergency; where schools, universities, workspace, cinemas, and sports venues are currently closed and air travel remains suspended. Outbreak is creating significant additional pressure on an already overburdened health system in the Member Countries. 

This brief is an attempt to assess the status of healthcare and ICT infrastructure in the ECO Member Countries and how these countries have responded during the outbreak of this this pandemic. Almost all ECO Countries are under the state of emergency; where schools, universities, workspace, cinemas, and sports venues are currently closed and air travel remains suspended.

The COVID-19 outbreak has infected more than 2,950,000 people and killed more than 202,000 

worldwide to this date1). While the overall economic impact of this outbreak is still unfolding, there 

are strong indications that it will cause the largest economic downturn since the 2008 financial crisis. 

This brief makes a case for protecting science, technology and innovation budgets during the 

COVID-19 crisis and its aftermath, based on the fact that continued investments in STI will be critical to 

the achievement of the 2030 Agenda for Sustainable Development. Even though developing countries as 

a group have recorded continued growth in R&D expenditure over recent years, the absolute levels 

remain small and their STI capabilities limited. It is therefore crucial for developing countries to reinforce 

their commitments to protect investment in STI and to design recovery packages that leverage technology 

and innovation for sustainable development. 

 I. Outline of the Japan Agency for Medical Research and Development (AMED)

 II. Domestic and international trends regarding the novel coronavirus (COVID-19)

 III. AMED's activities related to COVID-19

    1. AMED's initiatives in medical R&D

    2. Collaboration with related organizations

 IV. AMED R&D related to control for the novel coronavirus

China faces the year 2021 with both many about to begin its 14th Five-Year Plan which
involves significant adjustments to the trajectory of its development. It is also doubling down
on its commitments to scientific research and technological innovation as means for attacking
the challenges, including the launching of a new medium to long-term plan for science and
technology development intended to both secure China’s position in the industries of the future and
to bring novel technological solutions to major societal problems. 

China has spent several decades building its capabilities for science, technology, and innovation, and now enjoys a convergence of talent, facilities, and generous funding that can be directed to the fulfillment of goals for the 14th Plan and beyond. Yet, Plan implementation will not be without problems as an examination of the strengths and weaknesses of China’s response to COVID-19 illustrates. 

Previous pandemics in the modern era were never long, severe or widespread enough to stimulate an all-of-science approach to beating them. SARS essentially ended after only several months in 2003, H1N1 caused approximately 18,000 deaths in 2009~2010, and Ebola was concentrated in West Africa in 2014~2016 and in the Democratic Republic of Congo in 2019~2020. During these pandemics, the medical sciences fought back through genomic research, vaccine development  and new treatments, but their limited nature did not trigger a response from non-medical branches of science. 

COVID-19 is a much more severe pandemic, with no end in sight, more than a million deaths already, and affecting every country in deep ways. As a result, more branches of science are getting involved in the pandemic response, such as transport engineering, fluid mechanics, mathematical modelling and even astronomy. 

While politicians close borders to curb the spread of COVID-19, researchers in the medical and non-medical areas are breaking borders by communicating and working on the solution for COVID-19. This is on top of the decade-long partnership in pandemic responses between economists, sociologists and behavioral psychologists with public health experts and doctors. This all-of-science response is both necessary and admirable. However, such energetic responses can and should be harnessed in several ways to fully maximize the benefits. This article proposes three over-arching principles for country-level governments and the self-governing global science community to consider. 

The Coronavirus (COVID-19) has been leaving its imprints and implications on almost every corner
sustaining the relevance and resilience of the ASEAN Community further beyond. International coordination and cooperation is of increasing demand and necessity. The pandemic has, therefore, brought to the fore the question of resilience - national, regional, and global, particularly in terms of effective policy response. This article analyses the COVID-19 response by the Association of Southeast Asian Nations (ASEAN) and Vietnam as the ASEAN Chair in the year 2020. The argument is that COVID-19 has served as a reminder of the importance of science, technology and innovation, the real necessity for science-based policies, and the greater demand for national and regional resilience and good governance to deal with emerging challenges. 

For Southeast Asia, the spirit of cohesiveness and responsiveness that Vietnam demonstrated and promoted in its ASEAN chairmanship year 2020 has been and will be determinant in the response to COVID-19 and sustaining the relevance and resilience of the ASEAN Community further beyond.

The COVID-19 pandemic has disrupted almost all areas of daily lives, including research. While
fit a world where crisis is the new normal. presented great opportunities for research to improve moving forward. Key challenges for health research include: erosion of public trust on clinical trials due to concerns that procedures are being cut with regard to safety and efficacy; difficulties to conduct research
due to pandemic circumstances; and distortion of health research priorities and funding. 

Key opportunities for health research include: extra time to conduct pending studies, data analysis,
manuscript writing as well as to pursue new research ideas and acquire new skills; increased
public appreciation of research; and momentum for universities to change. Researchers and
research institutions should draw more attention to opportunities and shift to a more positive
narrative to mobilise for change. Now is the time to reconstruct research models and paradigms to
fit a world where crisis is the new normal.

Many therapeutic strategies have been devised to combat the COVID-19 pandemic, including the
the development of new treatments from the assets and policy interventions that can be implemented.
Unfortunately, the current strategies are either not yet available, or have not convincingly and unequivocally shown the desired efficacy needed to combat the pandemic. The identification of active compounds in plant-derived medicines can lead to new antivirals in the future, which makes plant biodiversity an indispensable resource. 

Countries that have high biodiversity such as Indonesia can play an important role in the elucidation and development of new plant-derived medicines and antivirals. In this article, we highlight the potential of Indonesia’s assets such as its plant diversity and a strong history of utilizing traditional medicines to fight the current pandemic. We also introduce possible roadmaps for the development of new treatments from the assets and policy interventions that can be implemented.